At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Feb 22, 2026 at 19:00 ET
Multiple top executives at Vir Biotechnology, including the CEO, CFO, and Chief Medical Officer, sold shares in a coordinated cluster over two days, totaling over $206,000 in sales. The same insiders also received stock awards totaling 450,000 shares, indicating a routine grant or vesting event. The sales appear to be part of a planned transaction, likely related to tax or diversification strategies following the award vesting.
- CEO Marianne De Backer sold $141,894 worth of shares, the largest individual sale.
- All four C-suite insiders sold shares at $7.4528 per share on 2026-02-23, immediately after receiving large stock awards on 2026-02-22.
- Total sales value: $205,159.35 across 27,662 shares.
- Insiders collectively received 450,000 shares via awards at $0 cost, consistent with vesting of prior grants.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access